Results 71 to 80 of about 372,846 (179)
Method Development and Validation of RP-HPLC Method for the Estimation of Sitagliptin Phosphate in Tablet Dosage Form [PDF]
Method Development and Validation of RP-HPLC for the Estimation of Sitagliptin Phosphate in Tablet Dosage Form was developed using Qualisil C18 BDS Column(150×4.5mm,5µ) as stationary phase and Potassium dihydrogen phosphate and Acetonitrile in a ratio 60:
N. Gayathri, K. Prabhakaran, A. Naveen, M. Kavinilavu, S. Maheshboopathi, M. Manikandan, M. Kaviyarasu, N. Astalakshmi, M. Surendrakumar
core +1 more source
Objective: To explore how metformin, alone or in conjunction with sitagliptin, affects the leptin/adiponectin ratio in obese type 2 diabetes mellitus patients.
Hala Aqeel Shams +2 more
doaj +1 more source
GLP‐1 agonists and the gut microbiome: A bidirectional relationship
Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists have transformed the management of type 2 diabetes mellitus (T2DM) and obesity, yet their interactions with the gut microbiome remain an emerging frontier in pharmacological and metabolic research.
Srinivas Kamath +2 more
wiley +1 more source
Formulation Development and In-Vivo, In- Vitro Evaluation of Sitagliptin Phosphate Floating Microspheres [PDF]
The purpose of the present investigation was the development and characterization of gastro-retentive floating drug delivery system for anti-diabetic drug Sitagliptin Phosphate that would retain the drug in stomach and continuously release the drug in ...
Aftab Alam, S. Rajasekaran
core +1 more source
ENANTIOMETRIC SEPARATION OF SITAGLIPTIN IN A FIXED DOSE COMBINATION FORMULA OF SITAGLIPTIN AND METFORMIN BY A CHIRAL LIQUID CHROMATOGRAPHIC METHOD [PDF]
Objective: Sitagliptin phosphate and metformin hydrochloride tablet is an FDA approved combination product for the treatment of diabetes mellitus type 2. There are no reported evidence for estimation of undesired (S)-sitagliptin in a combination product.
PALANISAMY, KAMARAJ +2 more
core +1 more source
Eco‐Friendly and Economical Approach for Immobilization of Thermostable ω‐Transaminase
This work presents immobilization of thermostable ω‐Transaminase on diatomaceous earth using eco‐friendly Fe3+‐tannic acid complexes. The immobilized enzyme retains optimal activity and preserves over half its activity after repeated cycles, offering a simple, economical immobilization strategy for industrial biocatalysis.
Wasia Khanam +3 more
wiley +1 more source
A stability-indicating high-performance thin-layer chromatographic (HPTLC) method was developed for the simultaneous determination of sitagliptin phosphate monohydrate and pioglitazone hydrochloride in a combined antidiabetic mixture.
Riddhi B. Nagar +4 more
doaj +1 more source
Central illustration: Pathophysiological mechanisms linking diabetes mellitus and cardiovascular disease. Chronic hyperglycaemia, insulin resistance, and low‐grade inflammation contribute to endothelial dysfunction, myocardial fibrosis, and cardiomyocyte apoptosis.
Lilian Anagnostopoulou +13 more
wiley +1 more source
Hypoglycemia associated with off-label sitagliptin use
Heather P Whitley1,2, Kristi Kelley11Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Auburn, AL, USA; 2Department of Community and Rural Medicine, University of Alabama School of Medicine, Tuscaloosa, AL, USAPurpose: To ...
Heather P Whitley, Kristi Kelley
core
Analysis of published and unpublished sitagliptin (Januvia) studies in humans
August 25, 2014 5 pm Bogotá time zone Sitagliptin (Januvia) ClinicalTrials.gov records completed before Jan 2011. Total number of records = 115Expert search terms (PubMed): http://goo.gl/pIdDaQ Records not found = 85Results = 40 Expert search terms of ...
Jorge H Ramirez (587826)
core +1 more source

